Bitcoin Forms 4-Year Inverse H&S Pattern – Neckline Break Could Send It Parabolic

Bitcoin holds above $105K amidst volatility, forming an inverse head and shoulders pattern. A breakout above $112K could signal a bullish reversal and new all-time highs.

Decentralized Oracle Network Chainlink Continues Run As Most-Developed Project in the DeFi Sector: Santiment

Chainlink leads DeFi development activity, outpacing competitors in GitHub events, indicating strong developer confidence and project stability. LINK is currently priced at $12.83.

Chainlink (LINK) On Standby: Bitcoin’s Next Move Holds The Key

Chainlink is in a holding pattern, awaiting Bitcoin's direction. Key support at $12.50 and falling wedge pattern suggest potential bullish movements, but uncertainty persists.

Trump cuts off US trade talks with Canada, shattering optimism over tariff deals

Trump halted trade talks with Canada over a new digital services tax, citing it as a direct attack, and plans to impose tariffs soon.

Summertime data to pave way for Fed rate cuts, or further conflict with Trump

Underlying inflation rose unexpectedly, complicating Fed rate decisions. Slowing spending and income raise concerns about economic growth amidst ongoing tensions with President Trump over monetary policy.

US Senate referee allows measure to slash CFPB budget, lawmakers say

The U.S. Senate allows Republicans to cut funding for the CFPB, potentially limiting its power, while Democrats vow to block the measure citing consumer protection concerns.

Brazil central bank sees rate cut debate as premature, says official

Brazil's central bank is not considering interest rate cuts, maintaining focus on inflation recovery and holding the rate steady at 15% for a prolonged period.

S&P 500, Nasdaq hit record highs on renewed AI bets, rate-cut hope

The S&P 500 and Nasdaq hit record highs driven by AI enthusiasm and looser monetary policy, as U.S. stocks recover from recent declines.

US senator probes GSK’s halt of children’s asthma inhaler

Senator Maggie Hassan is investigating GSK's decision to discontinue a children's asthma inhaler, citing health impacts and financial issues related to increased costs and access obstacles.

US consumer spending falls; tariff-related boost to inflation awaited